scPharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 48,622 | 0.135% |
| General Public | 1,226,147 | 3.4% |
| Individual Insiders | 1,990,122 | 5.52% |
| Public Companies | 2,167,679 | 6.01% |
| Hedge Funds | 3,500,000 | 9.71% |
| VC/PE Firms | 11,850,309 | 32.9% |
| Institutions | 15,271,530 | 42.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,559,528 | US$25.9m | 0% | 0.36% | |||
| 3,500,000 | US$16.3m | 29% | 0.52% | |||
| 3,183,986 | US$14.8m | 0% | 0.28% | |||
| 3,106,795 | US$14.5m | 40.8% | 5.73% | |||
| 2,167,679 | US$10.1m | 0% | no data | |||
| 1,825,234 | US$8.5m | 0% | no data | |||
| 1,801,610 | US$8.4m | -3.32% | no data | |||
| 1,404,607 | US$6.5m | 1,500% | 0.34% | |||
| 1,393,525 | US$6.5m | 48.8% | 0.03% | |||
| 1,369,888 | US$6.4m | 12.4% | no data | |||
| 1,200,647 | US$5.6m | 0% | 1.11% | |||
| 1,049,403 | US$4.9m | 0.65% | 0.01% | |||
| 871,488 | US$4.1m | 98% | 0.03% | |||
| 757,771 | US$3.5m | 647% | 1.33% | |||
| 567,211 | US$2.6m | 0% | 0.74% | |||
| 560,322 | US$2.6m | -46% | no data | |||
| 537,748 | US$2.5m | 5.07% | no data | |||
| 500,000 | US$2.3m | 0% | 0.09% | |||
| 356,873 | US$1.7m | -23.2% | no data | |||
| 281,105 | US$1.3m | 247% | 0.08% | |||
| 269,036 | US$1.3m | 0.02% | no data | |||
| 223,000 | US$1.0m | -1.59% | 0.02% | |||
| 196,755 | US$916.9k | -82.7% | no data | |||
| 173,573 | US$808.9k | -13.6% | no data | |||
| 144,000 | US$671.0k | 0% | 0.01% |